Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $35.67 $43.20 Wednesday, 8th May 2024 CLDX stock ended at $41.21. This is 2.37% less than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 3.98% from a day low at $40.72 to a day high of $42.34.
90 days $35.03 $53.18
52 weeks $22.11 $53.18

Historical Celldex Therapeutics prices

Date Open High Low Close Volume
Aug 09, 2016 $67.95 $71.40 $66.90 $70.20 129 267
Aug 08, 2016 $70.05 $70.20 $66.75 $67.80 160 820
Aug 05, 2016 $67.65 $70.65 $67.65 $69.90 118 747
Aug 04, 2016 $70.20 $70.65 $67.35 $67.65 90 860
Aug 03, 2016 $68.10 $69.90 $67.50 $69.90 84 907
Aug 02, 2016 $69.30 $70.80 $67.35 $68.25 97 360
Aug 01, 2016 $69.75 $71.25 $69.15 $70.05 121 540
Jul 29, 2016 $70.35 $70.35 $68.70 $69.30 84 413
Jul 28, 2016 $71.85 $72.45 $69.60 $70.80 97 760
Jul 27, 2016 $70.35 $71.70 $69.90 $71.55 99 027
Jul 26, 2016 $70.35 $71.55 $68.85 $69.90 108 373
Jul 25, 2016 $71.25 $71.70 $69.60 $70.80 46 587
Jul 22, 2016 $71.40 $72.00 $70.50 $71.10 92 120
Jul 21, 2016 $70.65 $72.15 $69.90 $71.10 162 340
Jul 20, 2016 $67.50 $70.05 $67.50 $69.90 125 467
Jul 19, 2016 $70.50 $71.10 $67.05 $67.20 132 040
Jul 18, 2016 $70.20 $71.55 $69.45 $70.65 90 933
Jul 15, 2016 $67.35 $70.50 $66.15 $70.50 104 247
Jul 14, 2016 $66.90 $67.80 $66.00 $67.20 105 580
Jul 13, 2016 $69.45 $69.60 $65.85 $66.30 164 487
Jul 12, 2016 $69.75 $70.50 $68.40 $69.15 106 687
Jul 11, 2016 $70.50 $70.80 $68.40 $68.55 85 453
Jul 08, 2016 $69.90 $70.95 $68.85 $69.60 99 347
Jul 07, 2016 $68.40 $70.35 $68.10 $69.75 60 853
Jul 06, 2016 $67.50 $70.05 $66.75 $69.45 115 333
Click to get the best stock tips daily for free!

About Celldex Therapeutics

Celldex Therapeutics Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity... CLDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT